A Year Later: Indie Scientist, Ethan Perlstein
Social media sites are all the fad. But how much are they really impacting life science?
Ask Ethan Perlstein that question, and he’ll tell you “a lot.”
Social media sites are all the fad. But how much are they really impacting life science?
Ask Ethan Perlstein that question, and he’ll tell you “a lot.”
Monday mornings won’t be the same in biotech.
Luke Timmerman announced last week that he’ll no longer be writing his Monday morning BioBeat column or serving as National Biotech Editor at Xconomy.
Timmerman’s voice has stood out in our industry for consistency, optimism, pragmatism . . . and great sports analogies.
Source: Xconomy
Guest:
Dan Graur, PhD, Professor, University of Houston Bio and Contact Info
Listen (3:09) Study of biology overtaken by hype
Listen (4:55) Scientist vs. technician
Listen (6:34) Public unaware that all they eat are GMOs
Listen (3:58) Do you have a role as a scientist to reach out to the lay audience?
Listen (2:27) What was your reaction to gene patent decision?
Listen (1:43) Thoughts on clinical genomics
Listen (2:04) Twitter and the Very Angry Evolutionary Biologist
We're happy to welcome Dan Graur, Professor of Biology and Biochemistry at the University of Houston, back to the program. Dan and his colleagues caused a stir in the world of genetics with their publication "On the Immortality of Television Sets," a sarcastic and witty criticism of the ENCODE Project and ensuing claims about the death of "junk DNA."
In today's interview, Graur says that he's always been a critic of bad science. He sees a trend where technicians and tools folks are masquerading as scientists.
"What happened in recent years," he says, "is that we have a huge influx of people who are not versed in the basics of population genetics and molecular evolution, and such. They are all essentially people who know how to write computer programs, who believe that science is not driven by questions, but it's driven by a sort of high tech natural history--the data will tell us what is in there."
Is not biology an information science? Does not the new biologist need to be a bioinformatician as well? Graur says we do not need to reinvent the wheel when it comes to basic science. (We'll be pursuing this question in an upcoming series, "The Bioinformatician Bottleneck")
Graur is currently working on a book about GMOs for the lay audience. He also shares his thoughts on gene patents, clinical genomes, and that marvelous "time waster", Twitter.
Podcast brought to you by: See your company name here. - Promote your organization by aligning it with today's latest trends.
My first LinkedIn invite was sent by a young businessman named Greg Cruikshank. He was listed as the founder of Labroots.
Not knowing a thing at the time about social media, I wanted to understand more about this site that expected me to type in my resume and share it with the whole world. And who was Greg Cruikshank and Labroots?
Guest:
Erik Clausen, Managing Partner and Vice President of Public Relations, Chempetitive Group Bio and Contact Info
Listen (6:29) PR basics still the same
Listen (6:11) Successful blogging
Listen (5:17) Personal vs. company Twitter handles
Erik Clausen has been in PR for twenty years. He's now a managing partner for Chempetitive Group, a life science PR and marketing firm. What has changed for PR professionals in today's world of Twitter, Facebook, and company blogs? What makes a company's blog successful? Are the rules of PR changing? Erik give his tips in our second show on the topic of life science PR.
Listen to the first interview with Erik on PR Tips for Scientists
Greg Cruikshank, President, BioConferenceLive Bio and Contact Info
Steve Shiflett, Technical Product Manager, Thermo Fisher Scientific Bio and Contact Info
Listen (5:10) Highlights of upcoming BCL Fall 2012
Listen (5:17) A run-down on the all new Labroots
Listen (4:15) Steve Shiflett of Thermo talks of exhibiting
For the 4th year in a row Bioconference Live has been producing virtual conferences for clinical diagnostics and the life sciences.. They put on three shows each year and this week is the Life Sciences conference Sept 12 and 13th. The conferences are free and are growing in number of speakers and audience. There’s a virtual exhibit hall where you can interact with various vendors. We have the founder of Bioconference Live, Greg Cruikshank on the line to tell us a bit about the show and then we’ll be joined by one of the participating exhibitors, Thermo.
Note: Theral will be speaking at the conference on Open Science:The People Behind the Movement on Wed at 11 am PST. Register for free.
Podcast Sponsor: Ingenuity - iReport, the fastest and most accurate way to get biological meaning from your expression data. www.ingenuity.com/get iReport/
Guest:
Michael Yared, Director of Digital Strategy, Chempetitive, Bio and Contact Info
(Listen to Each Chapter or Move the Marker for Video)
Listen (3:52) What Is Digital Marketing? (Begins at 0:59)
Listen (6:56) Using LinkedIn More (Begins at 4:53)
Listen (6:31) Search Marketing and How to "Google-Proof" Your Business (Begins at 11:48)
Listen (3:32) Three Important Things to Remember with Digital Strategy (Begins at 18:20)
Listen (1:11) Were You Always the Geek? (Begins at 21:52)
Today we're in San Diego at the offices of Chempetitive Group, a marketing agency devoted to the life science industry. We're joined by Michael Yared, Director of Digital Strategy to talk about digital marketing. Michael relates the trends he sees and offers suggestions such as using a dashboard to keep track of ad statistics and how to "Google-proof" your business. In the end he offers three important things to keep in mind for your digital strategy.
- the world's largest cloud-based marketplace for research services. With Assay Depot, you can easily find the perfect research service provider and manage your project from anywhere in the world.
Guest:
Adam Regelmann, MD, PhD, Co-Founder, Quartzy Bio and Contact Info
Listen (4:18) Freeing scientists to do science
Listen (5:58) Web 2.0 for inventory
Listen (3:53) What is the business model?
Listen (5:29) Experience at Y Combinator
Listen (1:53) From MD to entrepreneurship
Don't like how inefficient your lab is? Go out and start a new website. That's what Adam Regelmann did. With Quartzy, Adam and his co-founder, Jayant Kulkarni, have brought web 2.0 to lab inventory and order management. No more stickies. Need some supplies? Log on first to Quartzy, go to your colleagues' profiles, and check to see if those supplies could be just down the hall. Scoring a $1.2 million round of seed money last December, Adam says the site has over 8,000 scientist members. He talks with us about the circumstances which led to the site and also his experience as the first biology related company to participate in the popular Y Combinator incubator.
Podcast Sponsor: Chempetitive Group - Adding "life" to life science marketing
Guest:
Hamid Ghanadan, President, The Linus Group Bio and Contact Info
Listen (2:01) Genesis of the Linus Group
Listen (1:39) Dissonance between marketers and scientists?
Listen (9:41) How to market to scientists
Listen (4:23) What is content-centric marketing?
Listen (3:54) Demand generation
Listen (5:34) Company blogs- Are we all turning into journalists?
Listen (3:41) Dealing with 2012 marketing budget cuts
Listen (3:57) Pointers for using social media
Listen (2:24) New book out soon
Listen (4:03) Stereotypes of scientists
Today’s show is a must listen for anyone engaged in marketing in the life sciences. Hamid Ghanadan is President of The Linus Group, a marketing agency devoted to the life science industry. With a background in biochemistry, Hamid has created a unique company that specializes in understanding scientists and their buying behaviors. Hamid is also the editor and primary author of the Linus Report, the only publication offering critical briefings on science marketing issues.
Podcast Sponsor: ScienceExchange.com- The Scientific Services Marketplace
Guests:
Craig Lipset, Pfizer Bio and Contact Info
Listen (5:48) Bridging clinical research with eHealth
<img src="/images/speaker.jpg" alt=What happens when trial patients connect with each other online?"/> Listen (2:09) What happens when trial patients connect online?
Listen (4:01) How have patients changed?
Listen (2:51) What has Pfizer changed?
Listen (4:09) Challenges with mobile health?
Listen (4:58) How is Pfizer using social media?
Listen (9:44) Social media guidance
Listen (1:28) Pfizer and innovation
Listen (5:14) Clinical trials in 5 years
© 2023 de novo productions · Privacy · Terms· Underwriting · Contact